Zobrazeno 1 - 9
of 9
pro vyhledávání: '"León E Litwak"'
Autor:
Federico Pereyra-Bonnet, María L Gimeno, Nelson R Argumedo, Marcelo Ielpi, Johana A Cardozo, Carla A Giménez, Sung-Ho Hyon, Marta Balzaretti, Mónica Loresi, Patricia Fainstein-Day, León E Litwak, Pablo F Argibay
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e100369 (2014)
The conversion of differentiated cells into insulin-producing cells is a promising approach for the autologous replacement of pancreatic cells in patients with type 1 diabetes (T1D). At present, cellular reprogramming strategies encompass ethical pro
Externí odkaz:
https://doaj.org/article/d9dd9b23694d426caa0c1df6aa3f4827
Autor:
León E, Litwak, Ivanna, Querzoli, Carla, Musso, Alejandro, Dain, Solange, Houssay, Adrián, Proietti, José E, Costa Gil
Publikováno v:
Medicina (Buenos Aires), Vol 79, Iss 1, Pp 44-52 (2019)
An adequate glycemic control prevents and/or delays the development and/or progression of chronic complications in patients with diabetes mellitus (DM). To achieve this control, it is necessary to adjust insulin doses, in type 1 or insulinized type 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d71c869bb9c2b762f910bd064a6ba0d8
http://www.medicinabuenosaires.com/PMID/30694188.pdf
http://www.medicinabuenosaires.com/PMID/30694188.pdf
Publikováno v:
Medicina (Buenos Aires), Vol 78, Iss 4, Pp 225-233 (2018)
Diabetes mellitus is a true pandemic; type 2 diabetes in particular, with its progressive nature, constitutes a serious health problem. Despite advances and innovations in treatment, it continues to generate high morbidity and mortality. Many patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::158c10cce6fc6dda46a1c67848c2945e
http://www.medicinabuenosaires.com/PMID/30125249.pdf
http://www.medicinabuenosaires.com/PMID/30125249.pdf
Autor:
León E, Litwak
Publikováno v:
Medicina. 78(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9e09d2176ce639bfe557a94fc9b57291
https://pubmed.ncbi.nlm.nih.gov/29360083
https://pubmed.ncbi.nlm.nih.gov/29360083
Autor:
León E Litwak, Alicia Elbert, Cristina Faingold, Luis A. Grosembacher, Adrián Proietti, Félix Puchulu
Publikováno v:
Medicina (Buenos Aires), Vol 77, Iss 5, Pp 410-421 (2017)
Hyperglycemia during hospitalization is a common condition associated with poor prognosis. To date, insulin is the best strategy to treat hyperglycemia in these patients. An adequate glycemic control is associated with better clinical results. Nevert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f1d93b4d3565980e21bcf01645f6de93
https://pubmed.ncbi.nlm.nih.gov/29360082
https://pubmed.ncbi.nlm.nih.gov/29360082
Publikováno v:
Medicina (Buenos Aires), Vol 74, Iss 4, Pp 273-281 (2014)
Desde 1921, los beneficios alcanzados por las investigaciones sobre insulinoterapia han sido constantes. Sin embargo, el temor a las hipoglucemias y la rigidez horaria para administrar la insulina aún interfieren sobre la adherencia al tratamiento,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::3ec2f80c8eb690c4f0c61ac8e9440471
http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802014000400001&lng=en&tlng=en
http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802014000400001&lng=en&tlng=en
Autor:
Graciela V, Fuente, Isaac, Sinay, José E, Costa Gil, Félix, Puchulu, Guillermo, Dieuzeide, Martín, Rodríguez, María C, Faingold, León E, Litwak
Publikováno v:
Medicina. 76(3)
Diabetes mellitus is associated with vascular complications and high rates of morbidity and mortality. Timely insulin therapy, intensified when necessary, represent appropriate measures to prevent or delay the onset of complications. However, the inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::be627dee00d9277c5a62f5680de70331
https://pubmed.ncbi.nlm.nih.gov/27295707
https://pubmed.ncbi.nlm.nih.gov/27295707
Publikováno v:
Medicina. 74(4)
Since 1921, the benefits achieved by insulin therapy research have been constant. However, the fear of a hypoglycemia incidence and rigid time schedules of insulin therapy still interfere with treatment adherence, which is essential to achieve optima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2d92bc89d4819c2344bf58e5e124618a
https://pubmed.ncbi.nlm.nih.gov/25188652
https://pubmed.ncbi.nlm.nih.gov/25188652
Publikováno v:
Diabetes Care
OBJECTIVE To examine the efficacy and safety of rimonabant, a selective cannabinoid receptor type-1 antagonist, in patients with type 2 diabetes receiving insulin monotherapy. RESEARCH DESIGN AND METHODS Patients (n = 368; A1C ≥7%) were randomized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce7bf150c2f469d69b80a0ed77298d44
https://doi.org/10.2337/dc09-0455
https://doi.org/10.2337/dc09-0455